Cognex (NASDAQ:CGNX) Issues Q3 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) issued an update on its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.500-0.540 for the period, compared to the consensus estimate of 0.370. The company issued revenue guidance of $300.0 million-$320.0 million, compared to the consensus revenue estimate of $279.2 million. Cognex also updated its FY 2026 guidance to 1.640-1.680 EPS.

Cognex Trading Down 4.7%

Cognex stock traded down $3.33 during trading on Thursday, reaching $67.38. The company had a trading volume of 3,899,578 shares, compared to its average volume of 2,212,210. Cognex has a 52 week low of $34.60 and a 52 week high of $72.88. The firm has a market capitalization of $11.21 billion, a price-to-earnings ratio of 80.21 and a beta of 1.49. The firm’s 50-day simple moving average is $64.96 and its 200 day simple moving average is $56.90.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.03. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same period in the prior year, the firm posted $0.25 EPS. The firm’s quarterly revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, analysts predict that Cognex will post 1.48 earnings per share for the current year.

Cognex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be paid a $0.085 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s dividend payout ratio is 40.48%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CGNX. Stephens lifted their target price on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Zacks Research upgraded Cognex from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 16th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a research note on Thursday, May 7th. Wall Street Zen raised Cognex from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Cognex currently has a consensus rating of “Moderate Buy” and an average price target of $72.31.

Insider Buying and Selling

In related news, VP Laura Ann Macdonald sold 41,600 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at approximately $344,714.48. This represents a 88.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Darren Marc Long sold 20,252 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the transaction, the vice president owned 3,990 shares of the company’s stock, valued at $264,696.60. This represents a 83.54% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 224,847 shares of company stock worth $14,975,098. Corporate insiders own 1.70% of the company’s stock.

Cognex News Summary

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Earnings and outlook exceeded expectations: Cognex reported second-quarter EPS of $0.45, above the $0.42 consensus and up from $0.25 a year earlier. Management also issued third-quarter EPS guidance of $0.50–$0.54, well above the $0.37 analyst estimate, and raised full-year 2026 EPS guidance to $1.64–$1.68. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
• Positive Sentiment: Strong operating performance: Second-quarter revenue reached a record $291 million, up approximately 17% year over year, while net income increased to $72.8 million from $40.5 million. Margin improvement, favorable product mix and cost controls supported the earnings beat. Cognex Reports Second Quarter 2026 Results
• Positive Sentiment: Growth expectations remain favorable: Cognex forecast third-quarter revenue of $300 million–$320 million and full-year 2026 revenue of approximately $1.13 billion–$1.15 billion, with growth attributed to broad strength across major end markets.
• Neutral Sentiment: Dividend declared: The company announced a quarterly cash dividend of $0.085 per share, payable September 3 to shareholders of record on August 20. The roughly 0.5% yield is modest and is unlikely to be a major stock catalyst. Cognex Delivers Record Q2 Results and Raises Dividend
• Negative Sentiment: Revenue missed estimates: Quarterly revenue of about $291 million fell slightly short of the $292.1 million consensus. This miss appears to be outweighing the EPS beat and upbeat guidance in near-term trading.
• Negative Sentiment: Valuation and insider selling could add pressure: Cognex trades at a high earnings multiple, while reported insider activity showed sales and no purchases during the past six months. These factors may make investors less tolerant of even a small revenue miss.

Hedge Funds Weigh In On Cognex

Institutional investors have recently bought and sold shares of the business. Royal Bank of Canada increased its stake in Cognex by 13.2% during the first quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock worth $5,976,000 after acquiring an additional 23,326 shares during the last quarter. Empowered Funds LLC bought a new stake in shares of Cognex in the 1st quarter valued at approximately $291,000. Intech Investment Management LLC boosted its holdings in shares of Cognex by 24.1% in the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company’s stock worth $1,415,000 after purchasing an additional 9,223 shares during the period. Geneos Wealth Management Inc. boosted its holdings in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the period. Finally, Cetera Investment Advisers increased its position in shares of Cognex by 7.5% during the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock valued at $419,000 after purchasing an additional 920 shares during the last quarter. Institutional investors own 88.12% of the company’s stock.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.